查看完整行情页>>

|

货币单位:美元(USD)

阿比奥梅德

ABIOMED, Inc. (abmd)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Todd Tetreault Todd Tetreault currently works at ABIOMED, Inc., as Chief Financial Officer from 2023.
Karen Mahoney Karen Mahoney is currently the Chief Human Resources Officer & Vice President at ABIOMED, Inc. She started this position in 2019. Prior to her current role, she has worked at other undisclosed companies. Ms. Mahoney has an undergraduate degree from Assumption College and an MBA from Suffolk University.
Charles A. Simonton Charles A. Simonton is the founder of Cardiovascular Research Foundation, Carolinas Heart Institute. He is currently the Director at SpectraWAVE, Inc. and the Chief Medical Officer & Executive Vice President at ABIOMED, Inc. Previously, he worked as the Chief Medical Officer at Abbott Vascular Devices. He holds a doctorate degree from Harvard Medical School.
Will Danzinger Will Danzinger currently works at ABIOMED, Inc., as Chief Operating Officer from 2023 and Breethe, Inc., as Chief Operating Officer.
Andrew J. Greenfield Andrew J. Greenfield is currently the Chairman-Elect at the Massachusetts Medical Device Industry Council. He is also the President at ABIOMED, Inc. and Breethe, Inc. Mr. Greenfield previously worked as a Project Manager & European Country Manager at The Boeing Co. and as a Finance Manager at GE Healthcare Ltd. (United Kingdom) from 1999 to 2005. He holds an MBA from St. Louis University and an undergraduate degree from the University of Illinois, which he received in 1994.
Thorsten Sieß Thorsten Sieß is the founder of Impella Cardiosystems AG, a company founded in 1998. He held the title of Manager-Research & Development at Impella Cardiosystems AG. Currently, Dr. Sieß is the Managing Director, EVP & Chief Technology Officer at ABIOMED, Inc. since 2005. He is also the Co-Managing Director at ABIOMED Europe GmbH since 1998. Additionally, Dr. Sieß is a Director at Arterica, Inc. Dr. Sieß obtained his graduate and doctorate degrees from RWTH Aachen University.
Laxmi N. Peri Laxmi N. Peri is currently working as the Senior Vice President-Engineering at ABIOMED, Inc. Prior to this, Mr. Peri held the position of Vice President-Technology & Product Development at Thoratec Corp. Mr. Peri also served as the Senior Vice President-Operations at Zosano Pharma Corp from 2015 to 2016. Mr. Peri's education includes a graduate degree from Iowa State University, an MBA from the University of Minnesota, and an undergraduate degree from the National Institute of Technology.